{"id":"https://openalex.org/W4381377971","doi":"https://doi.org/10.2337/db23-415-p","title":"415-P: Reduction in the Risk of Peripheral Neuropathy and Preservation of Kidney Function with Metformin, Linagliptin, or Their Fixed-Dose Combination, Compared with Placebo in Prediabetes\u2014A Randomized Controlled Trial","display_name":"415-P: Reduction in the Risk of Peripheral Neuropathy and Preservation of Kidney Function with Metformin, Linagliptin, or Their Fixed-Dose Combination, Compared with Placebo in Prediabetes\u2014A Randomized Controlled Trial","publication_year":2023,"publication_date":"2023-06-20","ids":{"openalex":"https://openalex.org/W4381377971","doi":"https://doi.org/10.2337/db23-415-p"},"language":"en","primary_location":{"id":"doi:10.2337/db23-415-p","doi":"https://doi.org/10.2337/db23-415-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db23-415-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073467346","display_name":"Rafael Gabriel","orcid":"https://orcid.org/0000-0001-6084-6487","observed_orcids":["https://orcid.org/0000-0001-6084-6487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RAFAEL GABRIEL","raw_affiliation_strings":["Madrid, Spain, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Madrid, Spain, Helsinki, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101494461","display_name":"Jaakko O. Tuomilehto","orcid":"https://orcid.org/0000-0002-3424-0745","observed_orcids":["https://orcid.org/0000-0002-3424-0745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAAKKO TUOMILEHTO","raw_affiliation_strings":["Madrid, Spain, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Madrid, Spain, Helsinki, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12378887,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.023600000888109207,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.9549999833106995},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8820000290870667},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7680000066757202},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9480000138282776},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7680000066757202},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.7670000195503235},{"id":"https://openalex.org/keywords/lifestyle-modification","display_name":"lifestyle modification","score":0.8420000076293945},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.578000009059906},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.7639999985694885},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.7889999747276306},{"id":"https://openalex.org/keywords/sudoscan","display_name":"Sudoscan","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.9870542287826538},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9408079385757446},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8338394165039062},{"id":"https://openalex.org/C2779668308","wikidata":"https://www.wikidata.org/wiki/Q2087205","display_name":"Prediabetes","level":4,"score":0.754997730255127},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6811197400093079},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5949424505233765},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.58348149061203},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5312373638153076},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49146568775177},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.47808194160461426},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4403440058231354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42507749795913696},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.4185653328895569},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3404935598373413},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3240858018398285},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db23-415-p","doi":"https://doi.org/10.2337/db23-415-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db23-415-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4323314929","https://openalex.org/W2997614099","https://openalex.org/W4327786647","https://openalex.org/W4402027245","https://openalex.org/W6921489415","https://openalex.org/W2982238846","https://openalex.org/W4416452334","https://openalex.org/W3034310563","https://openalex.org/W4251453513","https://openalex.org/W2622626142"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"compare":[2],"the":[3,60,78,99,103,109,114,119,125,139,170,204],"effect":[4],"of":[5,50,62,89,93,238,245],"glucose-lowering":[6],"drugs":[7],"plus":[8],"lifestyle":[9,12],"modification":[10],"with":[11,22,35,77,138,153,159,169,184,199,203,215,220,224,234,241,249],"alone":[13],"on":[14],"peripheral":[15,65],"nerve":[16],"and":[17,80,122,168,202,226,240],"kidney":[18,246],"function":[19,247],"in":[20,29,59,98,108,113,118,124,187,230],"people":[21,90,219],"prediabetes.":[23],"Methods:":[24],"Multicenter,":[25],"randomized,":[26],"placebo-controlled":[27],"trial":[28],"658":[30],"individuals":[31],"aged":[32],"45-74":[33],"years":[34],"prediabetes":[36],"(IFG":[37],"or":[38,52,229],"IGT),":[39],"were":[40],"randomized":[41],"to":[42],"either":[43],"metformin":[44,115,160,200,225],"monotherapy,":[45,47,201,231],"linagliptin":[46,120],"fixed-dose":[48,140,171],"combination":[49,126,141,172,205],"linagliptin/metformin":[51,127,142],"masked":[53],"placebo.":[54,154,185,216,250],"Main":[55],"outcomes:":[56],"1-year":[57,222],"reduction":[58],"risk":[61,237],"small":[63],"fiber":[64],"neuropathy":[66],"(SFPN)":[67],"estimated":[68,81],"by":[69,96],"foot":[70],"electrochemical":[71],"skin":[72],"conductance":[73],"<70":[74],"\u00b5Siemens,":[75],"measured":[76],"SUDOSCAN\u00ae":[79],"glomerular":[82],"filtration":[83],"rate":[84],"(eGFR).":[85],"Results:":[86],"The":[87],"percentage":[88],"at":[91],"high-risk":[92],"SFPN":[94],"increased":[95],"29.6%":[97],"placebo":[100],"group,":[101,116,121],"while":[102],"increase":[104],"was":[105,156,190,232],"significantly":[106,136,157,191],"lower":[107,158,236],"three":[110,132],"active-drug":[111],"groups:1.8%":[112],"4.3%":[117],"3.9%":[123],"group":[128],"(p<0.001":[129],"for":[130],"all":[131],"comparisons).":[133],"eGFR":[134],"remained":[135],"higher":[137],"(3.3":[143],"mL/min;":[144],"95%":[145,176,195,209],"CI:":[146,177,210],"0.38;":[147],"6.22,":[148],"p":[149,180],"=":[150,181],"0.03)":[151],"than":[152,183,214,248],"FPG":[155],"monotherapy":[161],"(-0.3":[162],"mmol/L:":[163],"95%CI:":[164],"-0.48;":[165],"0.12,":[166],"p=0.0009),":[167],"metformin/linagliptin":[173,206],"(-0,2":[174],"mmol/L;":[175],"-0.37;":[178],"-0.03,":[179],"0.0219)":[182],"Reduction":[186],"body":[188],"weight":[189],"greater":[192],"(-2.0":[193],"kg/year,":[194],"CI:-5.65;":[196],"-1.65,":[197],"p=0.0006)":[198],"(-1.9":[207],"kg/year;":[208],"-3.02;":[211],"-0.97,":[212],"p=0.0002)":[213],"Conclusion:":[217],"In":[218],"prediabetes,":[221],"treatment":[223],"linagliptin,":[227],"combined":[228],"associated":[233],"a":[235,242],"SFPN,":[239],"better":[243],"preservation":[244],"Disclosure":[251],"R.Gabriel:":[252],"None.":[253],"J.Tuomilehto:":[254],"Stock/Shareholder;":[255],"Orion":[256],"pharma.":[257],"Funding":[258],"European":[259],"Commission":[260],"(FP7EC-GA":[261],"279074);":[262],"Boehringer":[263],"Ingelheim":[264],"Germany":[265],"(1218.166);":[266],"Merck":[267],"Healthcare":[268],"KGaA":[269],"(EMR200084_621);":[270],"Instituto":[271],"de":[272],"Salud":[273],"Carlos":[274],"III":[275],"(PI11/01653)":[276]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-06-21T00:00:00"}